Barclays »

Liminatus Pharma Inc A shares owned by Barclays

Quarter-by-quarter ownership of Liminatus Pharma Inc A (LIMN) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Liminatus Pharma Inc A

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma Inc A held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma Inc A by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $474 4.3k 0.11
2025-06-30 $2.0k 184 10.87

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Liminatus Pharma Inc A

Cygnus Capital Advisors
XTX Topco
Geode Capital Management
Citadel Advisors
Vanguard Capital Management
Goldman Sachs Group
Intl Fcstone
Vanguard Fiduciary Trust
State Street Corporation
UBS Group
JustInvest
Tower Research Capital
Citigroup
Barclays
BlackRock

View all funds holding Liminatus Pharma Inc A